MEEDER ASSET MANAGEMENT INC - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 14 filers reported holding Astellas Pharma Inc in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q3 2022$1,00077
+234.8%
0.00%
Q2 2022$0230.0%0.00%
Q1 2022$0230.0%0.00%
Q3 2021$0230.0%0.00%
Q2 2021$0230.0%0.00%
Q1 2021$0230.0%0.00%
Q4 2020$0230.0%0.00%
Q3 2020$0230.00%
Other shareholders
Astellas Pharma Inc shareholders Q4 2020
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 391,745$5,438,8800.25%
Cassady Schiller Wealth Management, LLC 698$9,6670.01%
MAI Capital Management 19,087$264,3620.00%
SVB WEALTH LLC 10,472$145,0370.00%
RHUMBLINE ADVISERS 34,759$481,4080.00%
First Horizon Advisors, Inc. 114$1,5780.00%
Operose Advisors LLC 90$1,2470.00%
Russell Investments Group, Ltd. 783$10,8450.00%
PNC FINANCIAL SERVICES GROUP, INC. 166$2,2990.00%
View complete list of Astellas Pharma Inc shareholders